Selective Induction of Apoptosis: Promising Therapy in Pancreatic Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|19|12|2259-2268

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.12, 2013-04, pp. : 2259-2268

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Induction of Apoptosis by Curcumin and Its Implications for Cancer Therapy

By  

Current Cancer Drug Targets, Vol. 5, Iss. 2, 2005-03 ,pp. : 117-129

Bentham Science Publishers

Access to resources Recommend Favorite

TNF-α gene therapy looks promising in pancreatic cancer

By  

Inpharma, Vol. 1, Iss. 1666, 2008-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Glufosfamide promising for pancreatic cancer

By  

Inpharma, Vol. 1, Iss. 1608, 2007-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

A mutated p53 status did not prevent the induction of apoptosis by sulforaphane, a promising anti-cancer drug

By Fimognari Carmela   Sangiorgi Luca   Capponcelli Silvia   Nüsse Michael   Fontanesi Silvia   Berti Fausto   Soddu Silvia   Cantelli-Forti Giorgio   Hrelia Patrizia  

Investigational New Drugs, Vol. 23, Iss. 3, 2005-06 ,pp. : 195-203

Springer Publishing Company

Access to resources Recommend Favorite

New retinoids and protein tyrosine kinase inhibitors for the treatment of disseminated cancer: selective induction of apoptosis in malignant cells

By  

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 10, 1998-10 ,pp. : 1369-1374

Informa Healthcare

Access to resources Recommend Favorite